This house believes that sulphonylureas should not be used routinely as second-line treatments for patients with type 2 diabetesGwilt M, Ryder REJ, Holman RRBritish Journal of Diabetes 2016;16:88-92. Published:Jun-2016. doi:10.15277/bjd.2016.082

Impact of comorbid diabetes on quality of life and perception of angina pain in people with angina registered with general practitioners in the UKStone MA, Khunti K, Squire I, Paul SQual Life Res 2008;17:887-894. Published:Aug-2008. Epub:17-Jun-2008. PMID:18560992. doi:10.1007/s11136-008-9363-0